Immunovant Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Immunovant Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Immunovant Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Immunovant Inc. is IMVT:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Immunovant Inc. has its primary listing on NASDAQ. You can trade Immunovant Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Immunovant Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Immunovant Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Immunovant Inc..